http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112957459-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16034 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y30-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y30-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate | 2021-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112957459-B |
| titleOfInvention | Influenza virus-based tumor combined immune nanoparticle, preparation method thereof, and use thereof for preparation of nanovaccine |
| abstract | The invention relates to an influenza virus-based tumor combined immune nanoparticle and a preparation method thereof, in particular to mixing a cationic liposome solution, an influenza virus aqueous solution, a tumor cell membrane dispersion and a polyvinyl alcohol aqueous solution under ultrasonic conditions to obtain a uniform solution. Mixed liquid, the mixed liquid is evaporated to dryness and the residue is redissolved in ultrapure water or DMEM medium to obtain the nanoparticles. Among them, influenza virus can stimulate the systemic immune system to produce cytokine storm in vivo, and activate dendritic cells, macrophages and natural killer cells, which play an important role in tumor treatment, and then greatly increase the proliferation of T cells. Efficiency; the signals needed to promote tumor antigen-specific immune responses can be obtained from the tumor cell membrane to activate T cells, which can be used to control tumor growth. Cancer treatment is more efficient. |
| priorityDate | 2021-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 295.